{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/cardiovascular-outcome-trials-strategic-insights-country-and-site-distribution#webpage",
"url": "https://www.fortrea.com/insights/cardiovascular-outcome-trials-strategic-insights-country-and-site-distribution",
"name": "Cardiovascular outcome trials: strategic insights for country and site distribution",
"description": "This Fortrea white paper explores strategic insights related to country and site distribution planning within cardiovascular outcome trials across global clinical research environments. The content focuses on cardiovascular outcome trials, strategic country distribution, site distribution planning, global trial placement approaches, and operational considerations affecting cardiovascular clinical research programs. The white paper highlights considerations related to geographic trial distribution, country allocation strategies, regional operational variability, research site placement, and maintaining effective study execution across international cardiovascular outcome trials. Fortrea discusses planning approaches designed to support balanced country selection, improve research site distribution strategies, strengthen global study coordination, and support operational planning across cardiovascular clinical research programs. By integrating country and site distribution planning with cardiovascular outcome trial strategy and global operational considerations, the white paper provides insights into strategic country and site distribution in cardiovascular outcome trials across evolving international research environments."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Cardiovascular outcome trials: strategic insights for country and site distribution",
"item": "https://www.fortrea.com/insights/cardiovascular-outcome-trials-strategic-insights-country-and-site-distribution"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/cardiovascular-outcome-trials-strategic-insights-country-and-site-distribution#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/cardiovascular-outcome-trials-strategic-insights-country-and-site-distribution#webpage"
},
"headline": "Strategic Country and Site Distribution in Cardiovascular Outcome Trials | Fortrea White Paper",
"description": "This Fortrea white paper explores strategic insights related to country and site distribution planning within cardiovascular outcome trials across global clinical research environments. The content focuses on cardiovascular outcome trials, strategic country distribution, site distribution planning, global trial placement approaches, and operational considerations affecting cardiovascular clinical research programs. The white paper highlights considerations related to geographic trial distribution, country allocation strategies, regional operational variability, research site placement, and maintaining effective study execution across international cardiovascular outcome trials. Fortrea discusses planning approaches designed to support balanced country selection, improve research site distribution strategies, strengthen global study coordination, and support operational planning across cardiovascular clinical research programs. By integrating country and site distribution planning with cardiovascular outcome trial strategy and global operational considerations, the white paper provides insights into strategic country and site distribution in cardiovascular outcome trials across evolving international research environments.",
"genre": "White Paper",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-10-14",
"dateModified": "2024-10-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-10/WP%200034%20Cardio%20Strat%20Insights%20Country%20Site%20Dist_0823.pdf",
"encodingFormat": "application/pdf"
}
}
]
}